方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| 人畜共患病监测× | 兽用抗菌药物敏感性试验× | |
|---|---|---|
| 领域 | 兽医学 | 兽医学 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 1900s-present | 1960s-present |
| 提出者≠ | Veterinary epidemiology and public health | Clinical Laboratory Standards Institute (CLSI) and veterinary microbiology |
| 类型≠ | Population-level monitoring pipeline | Diagnostic laboratory pipeline |
| 开创性文献≠ | Kahn, C. M. (Ed.). (2002). The Merck Veterinary Manual (9th ed.). Whitehouse Station, NJ: Merck. link ↗ | Clinical and Laboratory Standards Institute (CLSI). (2023). Performance Standards for Antimicrobial Susceptibility Testing of Bacteria Isolated from Animals (CLSI M100, 4th ed., Veterinary Supplement). Wayne, PA: CLSI. link ↗ |
| 别名 | disease monitoring, epidemiological surveillance, public health surveillance | antibiotic sensitivity testing, MIC determination, resistance profiling |
| 相关 | 3 | 3 |
| 摘要≠ | Zoonotic disease surveillance is a systematic population-level monitoring approach that detects, tracks, and analyzes cases of infectious diseases transmissible between animals and humans. Formalized through veterinary epidemiology and integrated with public health systems since the early 1900s, modern surveillance programs employ case detection networks, laboratory confirmation, and data sharing to enable early warning of emerging threats and coordinated disease prevention across animal and human sectors. | Antimicrobial susceptibility testing (AST) is a systematic in vitro laboratory method that determines which antimicrobial agents are effective against an isolated bacterial or fungal pathogen. Standardized by the Clinical and Laboratory Standards Institute (CLSI) and other regulatory bodies since the 1960s, AST guides targeted therapeutic decisions, supports infection control, and generates epidemiological data on resistance patterns essential for combating antimicrobial resistance in animal populations. |
| ScholarGate数据集 ↗ |
|
|